By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
An essential study technique for comprehending biological processes in vivo and in real-time is bioluminescence imaging (BLI). Low signal-to-noise ratio (SNR), great sensitivity, and the ability to study processes in vivo without endangering the subject animal are some of the primary advantages of bioluminescence imaging.
Compared to more conventional imaging and biodistribution research using terminal endpoints, invasive procedures, or radiolabeling, bioluminescence imaging offers a reliable, sensitive, and high throughput alternative.
The Global Bioluminescence imaging market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.
2D optical and 3D optical tomography are both included in the IVIS Spectrum in vivo imaging system. For non-invasive longitudinal monitoring of disease progression, cell trafficking, and gene expression patterns in living animals, the system makes use of cutting-edge optical technologies for preclinical imaging research and innovation. It boasts a 3.9 cm field of view, high resolution (to 20 microns), and high sensitivity in vivo imaging of fluorescence and bioluminescence.
With its faultless optical and X-ray imaging capabilities, the PerkinElmer IVIS Lumina III XR is the ideal imaging solution. A precise overlay to see bioluminescence or fluorescence map activities with anatomical surface or X-ray features is made possible by the system’s Living Image software.
Even in the scientific community, a smartphone has immense imaging potential. Fluorescence tags have recently been used in biomolecular imaging on smartphones. Bioluminescence can be used in smartphone-based techniques to observe biological targets at different scales. A single cell’s bioluminescence may be picked up by the smartphone microscope.
